Clinical trials
Recruiting Phase 3 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
450 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 10 |
| 2022 | 27 |
| 2023 | 43 |
| 2024 | 84 |
| 2025 | 151 |
| 2026 | 123 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 450 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 52 |
| Merck Sharp & Dohme LLC | 29 |
| Eli Lilly and Company | 26 |
| Janssen Research & Development, LLC | 18 |
| Novartis Pharmaceuticals | 18 |
| Pfizer | 18 |
| Hoffmann-La Roche | 17 |
| GlaxoSmithKline | 15 |
| Boehringer Ingelheim | 14 |
| Takeda | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 34 |
| Breast Neoplasms | 22 |
| Diabetes Mellitus, Type 2 | 17 |
| Multiple Myeloma | 15 |
| Obesity | 15 |
| Crohn Disease | 14 |
| Neoplasm Metastasis | 13 |
| Overweight | 13 |
| Neoplasms | 12 |
| Lung Neoplasms | 11 |
Trials
Showing 1 to 25 of 450. Each trial links to its page on Pharma Observatory.
350 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.